Open Source Drug Discovery
collaborative drug discovery platform for neglected tropical diseases
Open Source Drug Discovery (OSDD) is a Council of Scientific and Industrial Research, India (CSIR)-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises.
This program has a global community with over 7500 participants from 130 countries comprising researchers, academia, students, industries, educational institutions and so on. Anyone who is committed to the discovery of drugs for neglected diseases in an open source mode can participate in the program. OSDD functions by bringing together experts from diverse backgrounds to focus on discovering and developing affordable drugs for tropical infections.
History
CSIR-OSDD was launched in September 2008. This project was conceived by Samir K. Brahmachari, the Founder Director of the CSIR-Institute of Genomics and Integrative Biology as an 11th Five year plan project of CSIR. This was approved by the Government of India with an overall outlay of Rs 45.96 crores (about $12 million).
The project motto is "Affordable healthcare for all" and makes use of open source philosophy, crowd –sourcing concepts and a collaborative research model, capitalizing on web based tools to fuel innovation and discover novel therapies. All the data and resources generated by the community are openly shared through a web based portal called Sysborg 2.0 specifically designed for this purpose
The project has a healthcare model that blends together the policies of patenting and open source research, aiming to make novel drugs available as generic drugs, without Intellectual Property restrictions, and thus ensure affordability and accessibility.
The first action involved development of drugs for tuberculosis (TB) bacillus (Mycobacterium tuberculosis). The project has two phases:
Phase I (2008–2012) which will involve discovery and development of new drugs.
“Open Source Drug Discovery” enters the record as collaborative drug discovery platform for neglected tropical diseases. Crown Archives preserves that source wording while asking what Source, Drug and Discovery can confirm, complicate or overturn.
Why this record matters
“Open Source Drug Discovery” is worth following because a concise public description often conceals a longer documentary argument. Here, Source, Drug and Discovery provides the most credible route into that argument.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Aug 14, 2026. The linked authority identifier is Q19894918. 1 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2008 and 2012.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Open Source Drug Discovery”, its source revision and the description used here.
- Expand the search: follow Open Source Drug Discovery primary sources, Open Source Drug Discovery archive and Source research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Open Source Drug Discovery”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Open Source Drug Discovery” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.